No influence of spironolactone on plasma concentrations of angiotensin-converting enzyme 2: Findings from the HOMAGE randomized trial - Université de Lorraine Accéder directement au contenu
Article Dans Une Revue Archives of cardiovascular diseases Année : 2021

No influence of spironolactone on plasma concentrations of angiotensin-converting enzyme 2: Findings from the HOMAGE randomized trial

Pierpaolo Pellicori

Dates et versions

hal-03579095 , version 1 (17-02-2022)

Identifiants

Citer

João Pedro Ferreira, Nicolas Girerd, Hans-Peter Brunner-La Rocca, Pierpaolo Pellicori, John Cleland, et al.. No influence of spironolactone on plasma concentrations of angiotensin-converting enzyme 2: Findings from the HOMAGE randomized trial. Archives of cardiovascular diseases, 2021, 114 (12), pp.814-817. ⟨10.1016/j.acvd.2021.10.003⟩. ⟨hal-03579095⟩
29 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More